Aortic Aneurysm, Abdominal; Biomarkers, Pharmacological; Carotid Artery Diseases; Randomized Controlled Trial
W. Eilenberg is a dedicated vascular surgeon at the Department of Surgery, Division of Vascular Surgery and has conducted his PhD project on the role of neutrophils in carotid disease, with a special focus on inflammatory components. In the last years, he has extended his research to the role of neutrophils and NETs in abdominal aortic aneurysms (AAAs). In close collaboration with Prof. Brostjan, PhD head of the associated research lab, he has investigated NET components as a novel biomarker and therapeutic target in AAA. Thus, with his expertise in clinics and research, W. Eilenberg is focused on translational science regarding the abdominal aortic aneurysm. Furthermore, he extended his research area on randomized control trials in AAA, presently metformin as “old medication, novel indication” and submitted a Horizon 2020 grant application with 10 international collaborators.
Techniques, methods & infrastructure
Translational research and multi-center clincial trials:
Mouse models for AAA, analyzing novel biomarkers for Neutrophil extracellular traps, translational analyis of new biomarkers in AAA disease through biobanking, consortium leader of an international multi-centre study in 8 different countries;